USP17L15: A Drug Target / Disease Biomarker (G100288520)
USP17L15: A Drug Target / Disease Biomarker
USP17L15 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and muscle. It is a member of the USP family of transmembrane proteins, which are involved in the regulation of cell signaling pathways. USP17L15 has been shown to play a role in the regulation of several cellular processes, including cell adhesion, migration, and survival.
One of the most promising aspects of USP17L15 is its potential as a drug target. Due to its involvement in multiple cellular processes, it is a potential target for a variety of therapeutic compounds. This is especially exciting as USP17L15 has been shown to be involved in the regulation of many important cellular processes, including cell adhesion and migration.
In addition to its potential as a drug target, USP17L15 has also been shown to be a valuable biomarker for several diseases. For example, USP17L15 has been shown to be overexpressed in several types of cancer, including breast, lung, and colorectal cancer. This suggests that it may be a useful biomarker for these types of diseases.
Another promising aspect of USP17L15 is its role in the regulation of cellular signaling pathways. USP17L15 has been shown to play a role in the regulation of several signaling pathways, including the TGF-β pathway and the NF-kappa-B pathway. This suggests that it may be a useful target for drugs that are designed to modulate these signaling pathways.
In conclusion, USP17L15 is a protein that has the potential to be a drug target or biomarker. Its involvement in multiple cellular processes makes it an attractive target for therapeutic compounds, and its role in the regulation of cellular signaling pathways makes it a valuable tool for the study of disease. Further research is needed to fully understand the potential of USP17L15 as a drug target and biomarker.
Protein Name: Ubiquitin Specific Peptidase 17 Like Family Member 15
Functions: Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes that may include cell proliferation, progression through the cell cycle, apoptosis, cell migration, and the cellular response to viral infection
The "USP17L15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about USP17L15 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
USP17L17 | USP17L18 | USP17L2 | USP17L20 | USP17L21 | USP17L24 | USP17L25 | USP17L26 | USP17L27 | USP17L29 | USP17L3 | USP17L5 | USP17L6P | USP17L7 | USP17L8 | USP17L9P | USP18 | USP19 | USP2 | USP2-AS1 | USP20 | USP21 | USP22 | USP24 | USP25 | USP26 | USP27X | USP27X-DT | USP28 | USP29 | USP3 | USP3-AS1 | USP30 | USP30-AS1 | USP31 | USP32 | USP32P1 | USP32P2 | USP32P3 | USP33 | USP34 | USP35 | USP36 | USP37 | USP38 | USP39 | USP4 | USP40 | USP41 | USP42 | USP43 | USP44 | USP45 | USP46 | USP46-DT | USP47 | USP48 | USP49 | USP5 | USP50 | USP51 | USP53 | USP54 | USP6 | USP6NL | USP6NL intronic transcript 1 (non-protein coding), transcript variant 1 | USP7 | USP8 | USP8P1 | USP9X | USP9Y | USPL1 | UST | UTF1 | UTP11 | UTP14A | UTP14C | UTP15 | UTP18 | UTP20 | UTP23 | UTP25 | UTP3 | UTP4 | UTP6 | UTRN | UTS2 | UTS2B | UTS2R | UTY | UVRAG | UVSSA | UXS1 | UXT | UXT-AS1 | VAC14 | Vacuolar H+ ATPase | VAMP1 | VAMP2 | VAMP3
